Formoterol (Foradil Aerolizer) for asthma.
D000280:Administration, Inhalation; D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000009:adverse effects; D000328:Adult; D000336:Aerosols; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000517:prevention & control; D018880:Atrial Premature Complexes / Q000139:chemically induced; D001986:Bronchial Spasm / Q000517:prevention & control; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004983:Ethanolamines / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000068759:Formoterol Fumarate; D006801:Humans; D000068299:Salmeterol Xinafoate; D013610:Tachycardia / Q000139:chemically induced
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D004983:Ethanolamines; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D000068759:Formoterol Fumarate